Intrinsiqq

Apotea AB (APOTEA.XSTO) Financials

All currency values in kr millions unless otherwise noted

Scroll

Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenuekr 7,203kr 6,541kr 5,450kr 4,883kr 4,580
Cost of Revenuekr 5,266kr 4,753kr 4,001kr 3,611kr 3,384
Gross Profitkr 1,938kr 1,788kr 1,449kr 1,271kr 1,195
Total Operating Expenseskr 1,634kr 1,525kr 1,335kr 1,222kr 1,061
Operating Incomekr 304kr 263kr 113kr 49kr 134
Non-Operating
Net Interest Expense-kr 12-kr 5-kr 6-kr 4-kr 3
Income Tax Expensekr 64kr 53kr 26kr 13kr 26
Net Income
Net Incomekr 226kr 212kr 82kr 18kr 105
Per Share Data
Revenue Per Sharekr 69.22kr 63.78kr 52.37kr 46.92kr 44.00
EPS (Basic)kr 2.20kr 2.09kr 0.84kr 0.19kr 1.01
EPS (Diluted)kr 2.20kr 2.09kr 0.84kr 0.19kr 1.01
Shares Outstanding104.1M102.6M104.1M104.1M104.1M
Dividends Per Sharekr 0.60kr 0.00kr 0.00kr 0.00kr 0.00

Related stocks: Pharmaceutical Retailers

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.